PTEN and neoplasm: Sublethal levels of ROS stimulate tumor cell proliferation by inhibiting tumor suppressors such as redox-sensitive phosphatase and tensin homologues (PTEN), thereby promoting the PI3K-Akt signaling pathway or stabilizing HIF1 α, and are associated with chemotherapy resistance and prevention of tumor cell death [51].